Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities

Research


Please find all related articles below.



High level conference discusses General Data Protection Regulation


On 4 December 2012 EPHA attended the 3rd annual Data Protection and Privacy Conference in Brussels. The event examined the Commission’s proposals for a revision of the data protection framework in the EU. The Data Protection and Privacy Conference brought together policy-makers, industry and regulators to discuss the principles and implications of the General Data Protection Regulation currently under discussion in the European Parliament and the Council. Vice-President and (...)
05/12/2012

Entrepreneurship and Innovation Programme on Agricultural Productivity and Sustainability


After being launched in February, the first conference of "The Entrepreneurship and Innovation Programme (EIP) on Agricultural Productivity and Sustainability – Priorities and Delivery Mechanisms" took place on 19 November. Over the last years it has become increasingly evident that a new approach to agricultural innovation and research is needed if the European farming is to meet the challenge of producing under new constraints of resource availability and in line with multiple (...)
04/12/2012

Council conclusions on Literacy


The Council of the European Union adopted a couple of conclusions on literacy during the 3201st Education, Youth, Culture and Sport Council meeting on 26 and 27 November in Brussels. Levels of literacy remain stagnant in most European countries and one in five European citizens has inadequate literacy levels. Taking into account the fact that literacy is a crucial life competence which empowers the individual citizen and that low literacy levels hold back economic growth and reduces (...)
03/12/2012

[Revised EPHA position] Clinical Trials


EPHA has revised its position on clinical trials following the European Commission’s release of a legislative proposal for a regulation over the summer. While the key elements remain the same, the updated version emphasises the need for clinical trials to go ahead so that different population groups can benefit from life-saving treatments, while underlining that patient safety must remain at the centre of the process, and not compromised by less rigid assessment procedures. The (...)
29/11/2012

European Innovation Partnership on Active and Healthy Ageing’s conference - Ageing can be an opportunity


The long-awaited First Conference of Partners of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) took place on 6 November in Brussels. One year after the delivery of the Strategic Implementation Plan, the six Action Groups presented their action plans. The conference was an opportunity for stakeholders, already part of an Action Group, to meet and collaborate with different group members, and for more recent stakeholders to have the opportunity to learn about (...)
29/11/2012

“Medicine shortages is a global public health problem,” by the Pharmaceutical Group of the European Union


The number of reports of medicine shortages in the EU is increasing. Shortages are occurring across the supply chain and all classes of medicines are affected, from complex chemotherapy agents and anaesthetics to diabetes, hypertension, and asthma medication. This article is a contribution by the Pharmaceutical Group of the European Union (PGEU) There are a number of reasons why some medicines are sometimes unavailable. The medicines supply chain is highly complex and its efficiency (...)
29/11/2012

[EPHA Briefing] Criteria for Independent Research


EPHA has produced a briefing on financial conflicts of interest and research in health in light of growing evidence from the tobacco, pharmaceutical and medical fields that the funding source for research may compromise results in favour of commercial interests . In this briefing, EPHA explores if there is a risk that these biases could be extended to nutrition and alcohol science. The purpose of the briefing is to explore academic literature, tools to protect research from conflicts of (...)
29/11/2012

EPHA seminar on General Data Protection


EPHA hosted a seminar on Monday 19 November 2012 to clarify certain elements of the proposal for a revision of the rules on data protection. The European Commission released its revision of the 1995 Data Protection legislation in January of this year, proposing a number of measures which directly affect public health. In order to examine the exact implications for areas such as healthcare, patient protection and medical research, EPHA hosted a seminar clarifying the health matters (...)
26/11/2012

Civil Society Contact Group writes to EU Council for an EU Budget that meets peoples’ needs and EU responsabilities


The extraordinary November Summit will focus solely on the EU Budget. Heads of State will defend the budget lines that their countries receive funds from. In this context, members of the Civil Society Contact Group call for a re-prioritisation of EU funds to where they have the biggest impact on the environment, extreme poverty, and people living in Europe. The 22-23 November European Council is a crucial summit for ensuring that the next MFF delivers adequate financing for sustainable (...)
21/11/2012

EPHA position on General Data Protection Regulation


EPHA’s position on the General Data Protection Regulation highlights the strengths and weaknesses of the existing proposal from the perspective of the health community and lays out the key provisions in protecting patient safety, individual rights and public health. The European Commission (EC) is currently reviewing its existing legal framework on data protection to ensure that the rules are fit for dealing with increasingly complex and sophisticated developments in technology and (...)
16/11/2012